NCT00463034Unknown不适用
Genetic Factors Affecting Breast Cancer Progression
适应症
试验速览
- 阶段
- 不适用
- 入组人数
- 1,800
- 试验地点
- 1
- 主要终点
- Correlation of inherited and acquired variations in candidate genes with breast cancer progression and survival
研究概览
简要总结
RATIONALE: Studying samples of blood and tumor tissue in the laboratory from patients with cancer may help doctors learn more about changes that occur in DNA and help doctors understand how patients respond to treatment.
PURPOSE: This clinical trial is assessing how changes in genes affect disease progression in women with newly diagnosed or metastatic breast cancer.
详细描述
OBJECTIVES:
Primary
- Correlate inherited and acquired variations in candidate genes with breast cancer progression and survival in women with newly diagnosed or metastatic breast cancer.
Secondary
- Establish a repository of blood and tumor samples from these patients, linked to a database of clinical, pathological, and treatment outcome data for future research studies.
研究设计
- 研究类型
- Observational
入排标准
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Correlation of inherited and acquired variations in candidate genes with breast cancer progression and survival
次要结局
- Establishment of a repository of blood and tumor samples
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
不适用
Genes That Affect Disease Outcome in Patients With Metastatic Colorectal CancerColorectal CancerNCT00467129University of Sheffield800
已完成
不适用
Studying Urine and Blood Samples in Women With Newly Diagnosed Breast CancerBreast CancerNCT00766454Wake Forest University Health Sciences1,104
已完成
不适用
SWOG 8897-A DNA Analysis in Predicting Treatment Outcome in Women With Breast Cancer in SWOG 8897Breast CancerNCT00896623SWOG Cancer Research Network1,577
已完成
不适用
Genetic Studies in Breast CancerBreast CancerOvarian CancerNCT00582322Memorial Sloan Kettering Cancer Center483
已完成
不适用
Study of Tissue Samples From Women Treated With Paclitaxel for Breast Cancer on Clinical Trial CALGB-9344 or CALGB-9741Breast CancerNCT00991263Alliance for Clinical Trials in Oncology3,677